NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/23/2026
Back to search
Official data from USPTO
NX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
NX
ST13
US500000079393467Class
1, 5, 9, 10, 42, 44
Filing
79393467
Registration
7862423
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/23/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 9, 10, 42, 44
Filing date
02/15/2024
Registration date
07/15/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/15/2025
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
84
Owner location
CH
Examiner
EDWARDS, ALICIA COLLINS
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Navignostics AG
A. J. (pessoa física)
Representatives
Nicholas D. Wells Legends Law Group, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic biomarkers for analyticalresearch and scientific use; diagnostic biomarkers for in vitro testing for scientific use; diagnostic biomarkers for use in assessment of genomic analysis for scientific use; diagnostic biomarkers for use in assessment of individual diagnoses of cancer; diagnostic preparations for science or research; diagnostic reagents for science or research diagnostic reagents for the diagnosis of diseases; chemicals for the production of medical diagnostic reagentsparticularly for cancer research
Class 5
Diagnostic preparations for medical purposes; diagnostic radiopharmaceutical preparations for medical purposes; pharmaceutical productsmedical and veterinary preparationspharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for the diagnosis and treatment of cancer; diagnostic pharmaceutical preparations; medical test kits comprising pharmaceutical preparations for individual medical diagnosis for cancer therapy; medical test kits comprising pharmaceutical preparations for use in oncology for cancer screening; medical test kits comprising pharmaceutical preparations for cancer diagnosis; medical test kits comprising pharmaceutical preparations for individual medical diagnosis in the field of protein imaging; Diagnostic test kits for use in oncology comprising pathology slides for testing tissue samples; test kits for use in oncology comprising sample tubes for testing tissue samples; diagnostic test kits comprising laboratory equipment for sample preparationprocessing and storage for cancer diagnosis; diagnostic test kits for individual medical diagnosis comprising sample collection equipment for tumour analysis
Class 9
Recorded computer programs for use in oncology for analysing tissue samples from patients; downloadable computer programs for use in oncology for analysing tissue samples from patients; downloadable software for the analysis of medical dataparticularly for cancer researchtreatment and diagnosis; software for the analysis of medical dataparticularly for cancer researchtreatment and diagnosis; downloadable software for the digital representation of tumors and tumor features; software for the digital representation of tumors and tumor features; downloadable software for high- resolution digital image representation of the molecular composition of cellular anomalies; recorded software for high-resolution digital image representation of the molecular composition of cellular anomalies; downloadable software for high- resolution digital image representation of a digital tumor; recorded software for high- resolution digital image representation of a digital tumor; downloadable software for the analysis of medical dataparticularly for cancer researchtreatment and diagnosis; recorded software for the analysis of medical dataparticularly for cancer researchtreatment and diagnosis
Class 10
Apparatus for tumour diagnosisImaging Mass Cytometry (IMC) apparatus; medical apparatusspectrometers for machine learning-based spectrum analysis of human blood plasma; Multiplex protein imaging scanners for medical diagnosis; apparatus for clinical diagnosisdigital imaging device; spectrum analyzers for use in medical diagnosis; apparatus used in implementing diagnosis tests designed to detect abnormal genetic mutations in proteinsspatial proteomics tools; diagnostic oncology apparatus for medical usedigital imaging device; diagnosticexaminationmonitoring equipmentmultiplex protein imaging equipment; medical test kits comprising tissue sampling equipment for the use in oncology for cancer screening; medical test kits comprising tissue analysis tools for individual diagnosis in the field of cancer therapy
Class 42
Medical research in the field of cancer; medical research in the field of cancer diagnosis; Medical research in the field of proteomics; Medical research in the field of oncology; Medical research in the field of oncological diagnostics; technical data analysis servicesmedical data analysis for cancer diagnostics; software-as-a-service (SaaS) featuring software for use in cancer diagnosis; platform-as-a-service (PaaS) featuring software for use in cancer diagnosis; software-as-a-service (SaaS) featuring software for cell analysis for use in oncology; platform-as-a-service (PaaS) featuring software for cell analysis for use in oncology; software-as-a-service (SaaS) featuring software for medical and scientific research in the field of cancer treatment and diagnosis; platform-as-a-service (PaaS) featuring software for medical and scientific research in the field of cancer treatment and diagnosis; software-as-a-service (SaaS) featuring software using machine learning in the field of medical diagnosis and researchparticularly for cancer researchtreatment and diagnosis; Platform as- a-service (PaaS) featuring software using machine learning in the field of medical diagnosis and researchparticularly for cancer researchtreatment and diagnosis; software-as-a-service (SaaS) featuring software for the analysis of medical dataparticularly for cancer researchtreatment and diagnosis; platform-as-a-service (PaaS) featuring software for the analysis of medical dataparticularly for cancer researchtreatment and diagnosis; software as-a-service (SaaS) featuring software for the digital representation of tumours and tumour features; platform-as-a-service (PaaS) featuring software for the digital representation of tumours and tumour features; software as-a-service (SaaS) featuring software for high- resolution digital image representation of the molecular composition of cellular anomalies; platform-as-a-service (PaaS) featuring software for high-resolution digital image representation of the molecular composition of cellular anomalies; software as-a-service (SaaS) featuring software for high- resolution digital image representation of digital tumors; platform-as-a-service (PaaS) featuring software for high- resolution digital image representation of digital tumors
Class 44
Pharmaceutical and medical consultingparticularly in the field of medical diagnostics and oncology; pharmaceutical and medical consulting for businesses in the medical and medical diagnostics field; pharmaceutical and medical consulting for cancer treatment; disease diagnosis services; cancer diagnosis servicesparticularly for enabling personalized and individual medical care; disease diagnosis servicesparticularly in the field of oncology; disease diagnosis services in the field of proteomics; medical analysis services for cancer diagnosis and prognosis; remote monitoring of medical data for medical diagnosis; medical analysis for the diagnosis and treatment of persons; remote monitoring of medical data for medical diagnosis and treatment; medical testing services relating to the diagnosis and treatment of disease; providing information in the field of cancer preventionscreeningdiagnosis and treatment; medical diagnosis and treatment of cancer; testing and analysis services being medical diagnostic services; medical diagnostic services for the indication of individual treatments; medical diagnostic services for the indication of individual cancer treatments; medical diagnostic services for the indication of individual treatments in the field of oncology; providing information concerning diagnosticprophylactic and therapeutic properties of pharmaceutical and biological products for prevention and treatment of diseasesdisorders and conditions; medical services; veterinary services; hygienic care for human beings; hygienic care for animals
Publications
History of USPTO decisions and trademark events.
27 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/26/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/06/2026
FIMP
FINAL DISPOSITION PROCESSED
02/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/15/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/27/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/10/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/15/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
07/15/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/27/2025
PUBO
PUBLISHED FOR OPPOSITION
05/27/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/21/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2025
RFNT
REFUSAL PROCESSED BY IB
10/26/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/04/2024
RFRR
REFUSAL PROCESSED BY MPU
10/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/01/2024
CNRT
NON-FINAL ACTION WRITTEN
09/30/2024
DOCK
ASSIGNED TO EXAMINER
09/06/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/06/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/11/2024
Continuous trademark protection
Get notified about every new filing that threatens NX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.